# YK Bioventures

> YK Bioventures is an exempt reporting adviser in Burlingame, CA, filing reports since 2024. Exempt reporting advisers do not report regulatory assets under management on Form ADV.

- CRD: 332081
- Filed as: YK BIOVENTURES
- Legal name: YK Bioventures Capital Partners LLC
- Reporting status: Exempt reporting adviser (status as filed: ERA - Active)
- Location: Burlingame, CA
- Filing period: October 2026
- Form ADV filing dated: March 31, 2026
- Public record (IAPD): https://adviserinfo.sec.gov/firm/summary/332081
- AdvisorCensus page: https://advisorcensus.com/firm/yk-bioventures-burlingame-ca-332081

## Quick answers

**Where is YK Bioventures located?**
YK Bioventures' principal office is in Burlingame, CA, according to its Form ADV.

**How does YK Bioventures report to regulators?**
YK Bioventures is an exempt reporting adviser, filing reports since 2024. Exempt reporting advisers file a shorter Form ADV. Status as filed: ERA - Active. CRD 332081.

**Does YK Bioventures report any disciplinary disclosures?**
Reports no disclosure items on Form ADV Item 11. The detail of any item is on the firm's public record on IAPD: https://adviserinfo.sec.gov/firm/summary/332081

## From the Form ADV filing

### Firm details
- Reporting since: 2024 (2 years)
- Employees: Not reported total, Not reported performing advisory functions
- Wrap fee program participation: Not reported
- Disclosures (Item 11): Reports no disclosure items on Form ADV Item 11.

### Websites listed on Form ADV (Item 1.I)
- LinkedIn @yk-bioventures

## Assets and staff over time

| Data period | Regulatory assets under management | Employees | Filing dated |
| --- | --- | --- | --- |
| October 2024 | Not reported | Not reported | September 4, 2024 |
| October 2025 | Not reported | Not reported | April 2, 2025 |
| October 2026 | Not reported | Not reported | March 31, 2026 |


## Source

Form ADV as filed, October 2026. Values appear as filed. Cite as: AdvisorCensus. YK Bioventures (CRD 332081): Form ADV filing data as of October 2026.